PAG
ADIL

Private Advisor Group’s Adial Pharmaceuticals ADIL Stock Holding History

Private Advisor Group’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34
Closed -$7K – 1671
2022
Q3 		$7K Hold
34
– – ﹤0.01% 1897
2022
Q2 		$29K Sell
34
-21
-38% -$19K ﹤0.01% 2052
2022
Q1 		$69K Hold
55
– – ﹤0.01% 2025
2021
Q4 		$92K Sell
55
-2
-4% -$3.94K ﹤0.01% 2032
2021
Q3 		$152K Sell
57
-2
-3% -$4.19K ﹤0.01% 1913
2021
Q2 		$93K Hold
59
– – ﹤0.01% 1908
2021
Q1 		$89K Buy
+59
New +$89.2K ﹤0.01% 1813

Other funds holding ADIL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Private Advisor Group's ADIL Position: Q4 2022 in Review

Private Advisor Group sold out of Adial Pharmaceuticals (ADIL) in Q4 2022, closing a stake of 34 shares — an estimated $7K sold.

Private Advisor Group first reported a position in ADIL in Q1 2021 and held it in 7 quarters. The position peaked at $152K in Q3 2021. 20 funds tracked by Wall St. Rank hold ADIL as of Q4 2022.

  • Private Advisor Group reported no remaining Adial Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 34 Adial Pharmaceuticals shares in Q4 2022, an estimated $7K.
  • Private Advisor Group first reported a position in Adial Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Private Advisor Group's Adial Pharmaceuticals position peaked at $152K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.